CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company
CERENOME, INC.
Sign in to watch- Ticker
- CNSY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330827593
- Phone
- 737.255.7194
- Business address
- 6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
- Former names
- PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 37 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-01 | HEDRICK MARC H Chief Executive Officer | Option exercise · Restricted Stock Units | −159,681 | 1,756,487 | ||
| 2025-10-01 | Sims Andrew John Hugh MacIntyre Chief Financial Officer | Option exercise | +38,323 | 48,138 | ||
| 2025-10-01 | Sims Andrew John Hugh MacIntyre Chief Financial Officer | Option exercise · Restricted Stock Units | −38,323 | 421,555 | ||
| 2025-08-22 | Lenk Robert P Director | Purchase | +110,000 | $0.49 | $54K | 139,327 |
| 2025-08-13 | HEDRICK MARC H Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +5,748,506 | 5,748,506 | ||
| 2025-08-13 | HEDRICK MARC H Chief Executive Officer | Grant or award · Restricted Stock Units | +1,916,168 | 1,916,168 | ||
| 2025-08-13 | Sims Andrew John Hugh MacIntyre Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +1,379,636 | 1,379,636 | ||
| 2025-08-13 | Sims Andrew John Hugh MacIntyre Chief Financial Officer | Grant or award · Restricted Stock Units | +459,878 | 459,878 | ||
| 2025-08-13 | Guse Kyle Director | Grant or award · Stock Option (Right to Buy) | +297,794 | 297,794 | ||
| 2025-08-13 | Guse Kyle Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2025-08-13 | HEDRICK MARC H Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +5,748,506 | 5,748,506 | ||
| 2025-08-13 | HEDRICK MARC H Chief Executive Officer | Grant or award · Restricted Stock Units | +1,916,168 | 1,916,168 | ||
| 2025-08-13 | Hawkins Richard J Director | Grant or award · Stock Option (Right to Buy) | +397,794 | 397,794 | ||
| 2025-08-13 | Clowes Howard Director | Grant or award · Stock Option (Right to Buy) | +297,794 | 297,794 | ||
| 2025-08-13 | Lenk Robert P Director | Grant or award · Stock Option (Right to Buy) | +297,794 | 297,794 | ||
| 2025-08-13 | Sims Andrew John Hugh MacIntyre Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +1,379,636 | 1,379,636 | ||
| 2025-08-13 | Sims Andrew John Hugh MacIntyre Chief Financial Officer | Grant or award · Restricted Stock Units | +459,878 | 459,878 | ||
| 2025-08-13 | van Es-Johansson An Director | Grant or award · Stock Option (Right to Buy) | +297,794 | 297,794 | ||
| 2025-02-18 | Hawkins Richard J Director | Grant or award · Stock Option (Right to Buy) | +40,122 | 40,122 | ||
| 2025-02-18 | Clowes Howard Director | Grant or award · Stock Option (Right to Buy) | +40,122 | 40,122 |
Page 5 of 53 · 1,048 trades